Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radhashree Maitra

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Plos One|June 17, 2025
Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepineAaron Shaykevich, Danbee Chae, Isaac Silverman, et al.
Investigational New Drugs|January 7, 2019
Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparibTitto Augustine, Radhashree Maitra, Jinghang Zhang, et al.
International Journal of Molecular Sciences|August 12, 2022
COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19Tzuriel Sapir, Zaelig Averch, Brian Lerman, et al.
Oncotarget|April 20, 2017
Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancerRadhashree Maitra, Titto Augustine, Yitzchak Dayan, et al.
Cancers|August 1, 2020
Protein Arginine Methyltransferase 5 as a Therapeutic Target for <i>KRAS</i> Mutated Colorectal CancerDavid Shifteh, Tzuriel Sapir, Moshe Pahmer, et al.
Plos One|June 19, 2008
Immunogenecity of modified alkane polymers is mediated through TLR1/2 activationRadhashree Maitra, Cristina C Clement, Giovanna M Crisi, et al.
Current Issues in Molecular Biology|July 26, 2024
Erlotinib Treatment in Colorectal Cancer Suppresses Autophagy Based on <i>KRAS</i> MutationAlexander Siegman, Aaron Shaykevich, Danbee Chae, et al.
NPJ Precision Oncology|February 8, 2019
Immunotherapeutic advances in gastrointestinal malignanciesDevika Rao, Ruwan Parakrama, Titto Augustine, et al.
Frontiers in Molecular Biosciences|August 26, 2024
Structural modifications and kinetic effects of <i>KRAS</i> interactions with <i>HRAS</i> and <i>NRAS</i>: an <i>in silico</i> comparative analysis of <i>KRAS</i> mutantsIsaac Silverman, Michael Gerber, Aaron Shaykevich, et al.
BMC Cancer|June 20, 2020
Immune characterization of metastatic colorectal cancer patients post reovirus administrationRuwan Parakrama, Elisha Fogel, Carol Chandy, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Plos One|June 17, 2025
Modulating autophagy in KRAS mutant colorectal cancer using combination of oncolytic reovirus and carbamazepineAaron Shaykevich, Danbee Chae, Isaac Silverman, et al.
Investigational New Drugs|January 7, 2019
Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparibTitto Augustine, Radhashree Maitra, Jinghang Zhang, et al.
International Journal of Molecular Sciences|August 12, 2022
COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19Tzuriel Sapir, Zaelig Averch, Brian Lerman, et al.
Oncotarget|April 20, 2017
Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancerRadhashree Maitra, Titto Augustine, Yitzchak Dayan, et al.
Cancers|August 1, 2020
Protein Arginine Methyltransferase 5 as a Therapeutic Target for <i>KRAS</i> Mutated Colorectal CancerDavid Shifteh, Tzuriel Sapir, Moshe Pahmer, et al.
Plos One|June 19, 2008
Immunogenecity of modified alkane polymers is mediated through TLR1/2 activationRadhashree Maitra, Cristina C Clement, Giovanna M Crisi, et al.
Current Issues in Molecular Biology|July 26, 2024
Erlotinib Treatment in Colorectal Cancer Suppresses Autophagy Based on <i>KRAS</i> MutationAlexander Siegman, Aaron Shaykevich, Danbee Chae, et al.
NPJ Precision Oncology|February 8, 2019
Immunotherapeutic advances in gastrointestinal malignanciesDevika Rao, Ruwan Parakrama, Titto Augustine, et al.
Frontiers in Molecular Biosciences|August 26, 2024
Structural modifications and kinetic effects of <i>KRAS</i> interactions with <i>HRAS</i> and <i>NRAS</i>: an <i>in silico</i> comparative analysis of <i>KRAS</i> mutantsIsaac Silverman, Michael Gerber, Aaron Shaykevich, et al.
BMC Cancer|June 20, 2020
Immune characterization of metastatic colorectal cancer patients post reovirus administrationRuwan Parakrama, Elisha Fogel, Carol Chandy, et al.
Pageof 5